UK pharmacists to press government to act urgently on medicine supply problems caused by PI

3 December 2009

As a result of the recent advent of parallel importing of drugs from the UK, the Royal Pharmaceutical Society of Great Britain (RPSGB), which represents pharmacists, says that it will be calling on government to take urgent action to resolve the immediate crisis in medicines availability to prevent patients being put at risk of potential serious harm as a result of being unable to obtain appropriate medication.

The RPSGB Council has taken this step in response to increasing stock shortages across a range of widely supplied medicines for chronic conditions, shortages which appear in recent months to have worsened. Additionally the Society will be formally approaching the government to ask for the urgent establishment of an Inquiry into the supply of medicines to pharmacies to find a long term solution to this problem.

Currently, over 40 well known medicines are officially acknowledged to be in short supply. These fall across a wide range of therapeutic categories and include among many others, antihypertensives, epilepsy treatments and even some medicines to treat cancer and prevent rejection following organ transplantation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics